Novartis found to be in breach of code over drug brochureBMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f4061 (Published 21 June 2013) Cite this as: BMJ 2013;346:f4061
- Jacqui Wise
Novartis has been found to have made several breaches of the drug advertising code of practice over a brochure promoting a new drug for chronic obstructive pulmonary disease (COPD).1
The Drug and Therapeutics Bulletin made several specific complaints about the evidence used and the claims made in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial